20/20 Biolabs Inc. Stock Analysis & AI Score
20/20 Biolabs Inc. (AIDX) has an ST Score of 40.3 (C), driven by its Forecast (A) and held back by its Momentum (F). AIDX last traded at $0.42.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
20/20 Biolabs Inc. (AIDX) has an ST Score of 40.3 (C), driven by its Forecast (A) and held back by its Momentum (F). AIDX last traded at $0.42.
- Strongest
- ForecastA
- Weakest
- MomentumF
All factor grades
- ForecastA
- ValuationB+
- Financial StrengthB
- GrowthD
- ProfitabilityD-
- MomentumF
- Piotroski4/9
Contact
AIDX stock: frequently asked questions
What is AIDX's ST Score?
20/20 Biolabs Inc. (AIDX) has an ST Score of 40.3 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AIDX a buy, hold, or sell?
Our ST Score grades it C (40.3/100). The ST Score is a data-driven signal, not a recommendation.
What are AIDX's factor grades?
Valuation B+, Profitability D-, Financial Strength B, Momentum F, Growth D, Forecast A.
What is AIDX's valuation grade?
20/20 Biolabs Inc. (AIDX) earns a valuation grade of B+, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AIDX's growth grade?
20/20 Biolabs Inc. (AIDX) earns a growth grade of D, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AIDX's profitability grade?
20/20 Biolabs Inc. (AIDX) earns a profitability grade of D-, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AIDX's financial strength grade?
20/20 Biolabs Inc. (AIDX) earns a financial strength grade of B, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AIDX?
The average analyst price target for 20/20 Biolabs Inc. (AIDX) is $5.00, which is +1081.8% versus the recent price of $0.42.
What is AIDX's Piotroski score?
20/20 Biolabs Inc. (AIDX) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.